European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
By S. Travis, E. Stange, M. Lémann, Tom Øresland, Y. Chowers, A. Forbes, G. D'Haens, G. Kitis, A. Cortot, C. Prantera and 8 more. Gut, 2006
655 citations recorded by the source corpus.
Subfields: Epidemiology, Genetics
View Paper: https://www.semanticscholar.org/paper/c1e0d01491af4f3121528f32d2ee5fc2bcda24ab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- G. Macfarlane
- H. Steed
- C. Mowat
- S. Macfarlane
- A. Cole
- A. Windsor
- I. Arnott
- J. Satsangi
Citations in the corpus
- Guidelines for the management of inflammatory bowel disease in adults (2011, methodology): “The reader is referred to the ECCO consensus statement.(3)”
- Bacterial metabolism and health‐related effects of galacto‐oligosaccharides and other prebiotics (2007, background): “Furthermore, the success of sulfasalazine preparations and immune modulation using chimeric monoclonal antibodies in the treatment of rheumatoid arthritis and IBD to reduce levels of TNF-a and other pro-inflammatory cytokines, and disrupt inflammatory networks (Smolen et al. 1999; Bathon et al. 2000”